Related Experiment Video
Updated: Nov 8, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Genetics in Drug Discovery
Alexis Hubaud1, Ajeet Pratap Singh2
1Inzen Therapeutics, 790 Memorial Dr, Ste 202, Cambridge, MA 02139, USA.
Abstract:
Drug discovery is a complex process with high attrition rate: only about half of the compounds in advanced preclinical stages actually enter human trials. Key to these failures is our lack of understanding of human biology and the difficulties in translating our preclinical knowledge into cures. Here, we examine how genetics can be leveraged in drug discovery to understand and alter human biology.
Insights
Genetics can improve drug discovery by enhancing our understanding of human biology. This approach aims to reduce failures in clinical trials and accelerate the development of new medicines.
Area of Science:
- Pharmacology
- Genetics
- Translational Medicine
Background:
- Drug discovery faces high attrition rates, with many compounds failing before human trials.
- A significant challenge is the limited understanding of human biology and translating preclinical findings into effective treatments.
Purpose of the Study:
- To explore the application of genetics in drug discovery.
- To investigate how genetic insights can improve the understanding and manipulation of human biology for therapeutic purposes.
Main Methods:
- Review of genetic approaches in preclinical and clinical drug development.
- Analysis of case studies where genetics informed target identification and validation.
Main Results:
- Genetic data can provide deeper insights into disease mechanisms and patient stratification.
- Leveraging genetics can potentially increase the success rate of drug candidates.
Conclusions:
- Genetics offers a powerful tool to overcome key hurdles in drug discovery.
- Integrating genetic insights is crucial for advancing human biology understanding and developing targeted therapies.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Drug Discovery: Overview
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Incomplete Dominance
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...